生物相容性
癌症研究
体内
活性氧
材料科学
免疫系统
硒
肿瘤微环境
聚乙二醇
二硒醚
细胞毒性
老板
免疫学
体外
细胞生物学
生物
癌症免疫疗法
细胞
纳米载体
T细胞
谷胱甘肽
生物物理学
肿瘤进展
免疫疗法
癌症
先天免疫系统
化学
CD8型
纳米技术
淋巴细胞
树突状细胞
作者
Junhui Du,Qingxuan Meng,Xueyu Li,Qian Wang,Yuqing Miao,Yuhao Li
标识
DOI:10.1002/adfm.202521414
摘要
Abstract Tumor immunotherapy activated by external stimuli holds great promise but is hindered by limited natural killer (NK) cell activation and biocompatibility issues of therapeutic agents. Herein, a selenium‐rich bismuth‐based heterojunction (Bi 2 O 3−x Se x ‐Se‐PEG, BOSS) as a valence‐state transitive selenium nano‐reservoir for immuno‐activated cancer phototherapy is engineered. Synthesized via a topochemical‐like strategy with polyethylene glycol (PEG) modification, BOSS exhibits aqueous dispersibility and biocompatibility. Under 730 nm near‐infrared (NIR) light irradiation, BOSS efficiently converts light energy into heat and generates reactive oxygen species (ROS). More importantly, NIR light and tumor microenvironment (TME)‐overexpressed H 2 O 2 trigger the valence transition of selenium in BOSS from low‐valent (−2, 0) to high‐valent (+4), which downregulates HLA‐E expression on tumor cells, relieves NK cell inhibition and enhances their cytotoxicity. Concurrently, BOSS‐mediated glutathione depletion synergizes with ROS and heat to induce immunogenic cell death, releasing damage‐associated molecular patterns that promote dendritic cell (DC) maturation and activate thymus‐dependent lymphocyte (T cells), macrophages, and NK cells. In vitro and in vivo studies demonstrate that BOSS inhibits primary and distal tumor growth by activating systemic immune responses, while reducing toxic side effects associated with pre‐existing high‐valent selenium. This light‐controlled, valence‐variable nano‐system provides a versatile strategy for multi‐immune cell‐mediated tumor therapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI